Metlife INC Schedule 13D activist filings

MetLife's Board of Directors has amended its Schedule 13D filing to report beneficial ownership of 102,098,469 shares, representing 16.1% of the company's common stock, held through the MetLife Policyholder Trust.

The MetLife Board of Directors filed a Schedule 13D disclosing beneficial ownership of 103,885,196 shares held in the MetLife Policyholder Trust.

MetLife's Board of Directors filed an amendment to Schedule 13D, reporting beneficial ownership of 105.37 million shares held by the MetLife Policyholder Trust, representing 16.2% of outstanding common stock.

MetLife's Board of Directors has reported beneficial ownership of 106.5 million common shares, representing 16.17% of the company's outstanding stock, held through the MetLife Policyholder Trust.

MetLife's Board of Directors reports beneficial ownership of 108.24 million shares held by the MetLife Policyholder Trust, representing 16.28% of common stock.

MetLife, Inc.'s Board of Directors has filed an amendment to its Schedule 13D, reporting beneficial ownership of 109,404,080 shares, or 16.3%, of the company's Common Stock held by the MetLife Policyholder Trust.

MetLife, Inc.'s Board of Directors has filed an amendment to its Schedule 13D, updating the beneficial ownership of shares held by the MetLife Policyholder Trust to 110,760,381 shares, representing 16.3% of outstanding common stock.